2025 Silent Capital Report now available. Where family offices and LPs are actually deploying. [Download for free →]
About usSign in

Symbiosis Capital Management

Status
Global HQ
Dublin, Ireland
Countries of investment
    Investment stages
      Industries
        About
        SymBiosis Capital Management is a biotechnology VC firm investing in cutting-edge biotherapeutics for serious diseases, including novel biologics and precision therapies, to revolutionize healthcare.
        Min check size
        -
        Max check size
        -
        Fund size
        NPS

        Investment Thesis

        Lead investor
        Co Invest
        Number of exits
        Preferred contact method

        Manager's Experience

        Bringing extensive expertise in early-stage investments, the fund manager has a robust portfolio spanning the technology and healthcare sectors across North America and Europe. With a strategic operator-first approach, they have successfully executed over 30 deals, demonstrating a keen ability to identify high-potential startups. Noteworthy exits include several high-growth companies that have positioned themselves as leaders in their respective fields. Their investment style emphasizes a data-driven methodology, ensuring informed decision-making throughout the investment process.

        Symbiosis Capital Management Contacts Information

        Fund number
        Vintage Year
        Net Internal Rate of Return
        Investment Multiple
        Capital Allocation
        Management Fee
        Carried Interest
        AUM
        Follow-on Investments
        Graduation Rate
        Write-Off Ratio
        Last profile update timestamp